Assessing Herbal Products with Health Claims

Abstract

Herbs, herbal extracts, or phytochemicals are broadly used as foods, drugs, and as traditional medicines. These are well regulated in Europe, with thorough controls on both safety and efficacy or validity of health claims. However, the distinction between medicines and foods with health claims is not always clear. In addition, there are several cases of herbal products that claim benefits that are not scientifically demonstrated. This review details the European Union (EU) legislative framework that regulates the approval and marketing of herbal products bearing health claims as well as the scientific evidence that is needed to support such claims. To illustrate the latter, we focus on phytoecdysteroid (PE)-containing preparations, generally sold to sportsmen and bodybuilders. We review the limited published scientific evidence that supports claims for these products in humans. In addition, we model the in silico binding between different PEs and human nuclear receptors and discuss the implications of these putative bindings in terms of the mechanism of action of this family of compounds. We call for additional research to validate the safety and health-promoting properties of PEs and other herbal compounds, for the benefit of all consumers.

Keywords:

• Herbal products
• health claims legislation
• QSAR
• ecdysteroids
• 20-hydroxyecdysone
• hormone nuclear receptors

ACKNOWLEDGMENT

The authors thank Prof. Angelo Vedani from Biographics Laboratory 3R, Switzerland, for his support with VTL analysis and Ruth Veale, Head of Food, Health, Safety and Environment Department at BEUC for sharing their market research